Yüklüyor......
Long-term safety of tiotropium/olodaterol Respimat(®) in patients with moderate-to-very severe COPD and renal impairment in the TONADO(®) studies
INTRODUCTION: The safety, lung function efficacy, and symptomatic benefits of combined tiotropium and olodaterol in patients with COPD were established in the 1-year TONADO(®) studies (NCT01431274; NCT01431287). As tiotropium is predominantly excreted by the kidneys, the long-term safety profile of...
Kaydedildi:
| Yayımlandı: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5987861/ https://ncbi.nlm.nih.gov/pubmed/29910611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S161489 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|